Ownership history in UBS Group AG · 3 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in ADVANCED BIOMED INC (ADVB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 4,324 | +965 | +28.7% | 0.00% | $1K | $5.84 |
| 2025 Q3 | REDUCED | 3,359 | -21,470 | -86.5% | 0.00% | $2K | $8.96 |
| 2025 Q2 | INITIATED | 24,829 | — | — | 0.00% | $17K | $14.00 |